Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NCT: NCT04634916 · RECRUITING
NCT IDNCT04634916
StatusRECRUITING
Start Date2021-03-26
Completion2027-09
Brief Summary
A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.
Frequently Asked Questions
What is Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System?
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System is a clinical trial registered under NCT04634916. Current status: RECRUITING.
What is the status of NCT04634916?
The current status of NCT04634916 (Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System) is: RECRUITING.
When did Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System start?
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System started on 2021-03-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.